Table 1.
Demographic details and indication for surgery
| Patient number | Gender | Age | DMEK indication |
|---|---|---|---|
| 1 | Female | 63 | PBK |
| 2 | Male | 68 | Fuchs |
| 3 | Male | 72 | PBK |
| 4 | Male | 71 | Fuchs |
| 5 | Female | 71 | PBK |
| 6 | Female | 71 | PBK |
| 7 | Female | 77 | PBK (amblyopiaa) |
| 8 | Female | 74 | PBK |
| 9 | Male | 61 | Unknown |
| 10 | Male | 72 | Fuchs |
| 11 | Female | 71 | Fuchs |
| 12 | Male | 89 | PBK |
| 13 | Male | 61 | Trauma |
| 14 | Female | 83 | PBK |
| 15 | Female | 72 | Fuchs |
| 16 | Male | 72 | Fuchs |
| 17 | Female | 89 | Fuchs |
| 18 | Male | 81 | PBK |
| 19 | Female | 78 | Fuchs |
| 20 | Female | 80 | PBK (lost to follow-upa) |
| 21 | Female | 91 | Fuchs (graft failurea) |
| 22 | Female | 85 | Possible amantadine toxicity |
| 23 | Female | 85 | Possible amantadine toxicity |
| 24 | Male | 84 | PBK |
| 25 | Female | 75 | PBK |
| 26 | Male | 82 | PBK |
| 27 | Female | 79 | PBK |
| 28 | Female | 70 | PBK |
| 29 | Female | 74 | PBK |
| 30 | Male | 71 | PBK |
| 31 | Male | 80 | PBK (amblyopiaa) |
PBK pseudophakic bullous keratopathy
aExcluded from analysis of final visual outcomes (n = 4)